Find

Department of Clinical Medicine

Infectious Diseases

Publications

Sort by: Date | Author | Title

Offersen, R., Søgaard, O. S., Melchjorsen, J., Tolstrup, M. & Østergaard, L. J. (2008). Differences in serological response to conjugated pneunococcal vaccination among haart-naive and haart treated HIV-infected individuals. Poster session presented at The 25th Annual Meeting of the Scandinavian Society for Antimicrobial Chemotherapy, København, Denmark.

Offersen, R., Melchjorsen, J., Paludan, S. R., Østergaard, L. J., Tolstrup, M. & Søgaard, O. S. (2012). TLR9-adjuvanted pneumococcal conjugate vaccine induces antibody-independent memory responses in HIV-infected adults. Human Vaccines & Immunotherapeutics, 8(8), 1042-7. https://doi.org/10.4161/hv.20707

Offersen, R., Nissen, S. K., Rasmussen, T. A., Østergaard, L. J., Denton, P. W., Søgaard, O. S. & Tolstrup, M. (2016). A novel toll-like receptor-9 agonist, MGN1703, enhances HIV-1 transcription and NK cell-mediated inhibition of HIV-1 infected autologous CD4+ T cells. Journal of Virology, 90(9), 4441-4453. https://doi.org/10.1128/JVI.00222-16

Offersen, R., Yu, W. H., Scully, E. P., Julg, B., Euler, Z., Sadanand, S., Garcia-Dominguez, D., Zheng, L., Rasmussen, T. A., Jennewein, M. F., Linde, C., Sassic, J., Lofano, G., Vigano, S., Stephenson, K. E., Fischinger, S., Suscovich, T. J., Lichterfeld, M., Lauffenburger, D. ... Alter, G. (2020). HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound. Cell Reports, 33(11), Article 108502. https://doi.org/10.1016/j.celrep.2020.108502

Offersen, R. (2017). HIV-latency: cellular and humoral immunomodulation. Fællestrykkeriet SUN Aarhus Universitet.

Öbrink-Hansen, K., Søgaard, O. S., Harboe, Z. B. & Schønheyder, H. C. (2012). Risk factors for pneumococcal nasopharyngeal colonization before and after pneumococcal conjugate vaccination in persons with HIV: brief report. Current H I V Research, 10(3), 252-5.

Öbrink-Hansen, K., Søgaard, O. S., Harboe, Z. B. & Schønheyder, H. C. (2012). Risk factors for pneumococcal nasopharyngeal colonization before and after pneumococcal conjugate vaccination in persons with HIV. Poster session presented at 8th international Symposium on Pneumococci and Pneumococcal, Iguacu Falls, Brazil.

Öbrink-Hansen, K., Hardlei, T. F., Brock, B., Jensen-Fangel, S., Kragh Thomsen, M., Petersen, E. & Kreilgaard, M. (2015). Moxifloxacin pharmacokinetic profile and efficacy evaluation in empiric treatment of community-acquired pneumonia. Antimicrobial Agents and Chemotherapy, 59(4), 2398-404. https://doi.org/10.1128/AAC.04659-14

Öbrink-Hansen, K., Juul, R. V., Storgaard, M., Thomsen, M. K., Hardlei, T. F., Brock, B., Kreilgaard, M. & Gjedsted, J. (2015). Population Pharmacokinetics of Piperacillin in the Early Phase of Septic Shock: Does Standard Dosing Result in Therapeutic Plasma Concentrations? Antimicrobial Agents and Chemotherapy, 59(11), 7018-26. https://doi.org/10.1128/AAC.01347-15

Öbrink-Hansen, K., Jensen-Fangel, S., Brock, B., Hardlei, T. F., Adelfred, A., Nejatbakhsh, Y., Kragh Thomsen, M. & Petersen, E. (2016). Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations. Journal of Cystic Fibrosis, 15(2), e13-4. https://doi.org/10.1016/j.jcf.2015.10.005

Displaying results 761 to 770 out of 1973

77

Revised 11.09.2025

-

Lotte Bjerregaard Snabe